109 results
Page 3 of 6
6-K
EX-10.1
7ug3gc
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-1.1
6b05ht3q7rgip9s
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
ftci1vewnlio
10 Feb 21
Prospectus supplement for primary offering
5:22pm
F-3MEF
EX-23.1
h11n xq5cqf
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm
F-3MEF
04z5wdno
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm
F-3MEF
EX-5.1
zgranz3kntrv9ia834
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm
424B5
wj95a
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
2c3n2uzp
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
wjvmn 4z3
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
c5v2mbkul9jg83za
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.1
go1b34hunv
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.1
6053i
13 Apr 20
Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials
8:32am
6-K
EX-4.1
qbecvkwzaocc 6cf
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.2
fee1alz
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
8l1ib1k97arw cr9
5 Mar 20
Report of Foreign Private Issuer
8:16am